'Welcome to mRNAge': Moderna Launches Campaign Touting the Potential of mRNA
Moderna is now pivoting its business strategy by using mRNA technology to address a range of respiratory diseases, including cancer, rare diseases, and cardiovascular diseases
Biotechnology company and mRNA vaccine developer Moderna has launched a new campaign in Australia focussing on the “possibilities” of mRNA technology.
This comes as the biotech company and the Australian
government work to produce 100 million mRNA vaccine doses per year at a
soon-to-be-completed manufacturing facility in 2024. ---More...
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy